Cell and gene therapies have provided therapeutic benefit to a number of patients and continue to be developed to treat an increasing variety of diseases and conditions. To ensure their safety and efficacy prior to patient use, these therapies must undergo analytical testing that adheres to regulatory standards and guidelines. This webinar provides a high-level overview of some of the regulatory requirements for cell and gene therapy products and sources of information to guide in their development.

Learning Objectives: 

1. Regulatory overview for cell and gene therapies

2. qPCR and dPCR technologies as essential analytical tools

3. Successes to guide therapy development